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Abstract 
Compartmentalisation of cellular processes is fundamental to regulation of metabolism in 
Eukaryotic organisms and is primarily provided by membrane-bound organelles. These organelles 
are dynamic structures whose membrane barriers are continually shaped, remodelled and 
scaffolded by a rich variety of highly sophisticated protein complexes. Towards the goal of bottom-
up assembly of compartmentalised protocells in synthetic biology, we believe it will be important to 
harness and reconstitute the membrane shaping and sculpting characteristics of natural cells. We 
review different in vitro membrane models and how biophysical investigations of minimal systems 
combined with appropriate theoretical modelling have been used to gain new insights into the 
intricate mechanisms of these membrane nanomachines, paying particular attention to proteins 
involved in membrane fusion, fission and cytoskeletal scaffolding processes. We argue that 
minimal machineries need to be developed and optimised for employment in artificial protocell 
systems rather than the complex environs of a living organism. Thus, well-characterised minimal 
components might be predictably combined into functional, compartmentalised protocellular 
materials that can be engineered for wide-ranging applications.!
!
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Introduction 
!
Scientists have long looked to nature to provide solutions to some of our greatest problems, from 
therapeutics and medical materials, to the environment and energy production. As the oft-quoted 
physicist Richard Feynman said ‘nature’s imagination is so much greater than man’s, she’s never 
going to let us relax.’!
!
This statement couldn’t be more evident than in the stunningly complex and vastly interlinked 
systems that make up each and every living cell. Cells are some of the most incredibly adept 
devices we know and understanding them is the first step towards manipulating and harnessing 
cells as machines and applying them in novel ways. !
!
One of the cell’s most ingenious skills is also one of its most simple: compartmentalisation. Cell 
biologists have been intrigued for decades by the organisational abilities of cells and their clever 
methods of compartmentalisation. The ability to keeps things separate sounds simple, and yet, 
behind the scenes lies hundreds of interacting proteins and precise pathways that orchestrate and 
permit a multitude of mini-reactions to occur independently, repeatedly and simultaneously in the 
space of one cell. Eduard Buchner commented in his 1907 Nobel Lecture that ‘We are seeing cells 
more and more clearly as chemical factories, where the various products are manufactured in 
separate workshops, the enzymes acting as the overseers.’!
!
This same complexity is one reason designing experiments to exclusively probe one aspect of a 
cell’s function can be near impossible in vivo, and yield results difficult to interpret.  Cell biology 
relies heavily on the use of models systems, which have considerably furthered the current 
understanding of how cells work, but lack the finer mechanistic detail.!
!
Synthetic biology¶ or reconstitution studies, addresses this issue by offering a powerful way to 
study proteins in a stripped down system that can be tightly controlled. Liu & Fletcher 1 outline the 
benefits succinctly; in vitro experiments can refine and confirm molecular processes outside of a 
complicating cellular environment, whilst providing insight into how these biological functions could 
be engineered towards new functions.  It is this idea that lies at the heart of synthetic biology; 
creating an interface between biology and engineering and the understanding to turn cell biology 
into a physical and engineering discipline. !
!
It’s important to appreciate there is so much more to synthetic biology than uncovering the secrets 
of how cells work. In vitro reconstitution experiments are slowly revealing a whole toolkit of proteins 
with enormous potential - the full scope of which is yet to be realised and with only man’s 
imagination as the limit to the possibilities. Occurring throughout cells, dynamic membrane 
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remodelling is gained by the precise interplay of proteins and lipids that are able to generate, 
sense and stabilise membrane curvature. !
!
Here, we introduce a handful of these proteins and the experimental setups that allowed 
deciphering the mechanisms through which they shape membranes together with examples of how 
this knowledge has been used to produce reduced models of membrane remodelling tools. The 
scope of this review is to present advances in recent in vitro studies of membrane deformation 
mechanisms by natural systems as an opportunity for developing new instruments for the 
generation of ad-hoc compartments leading to the engineering of functional protocells. First we 
give an overview of different model membrane systems and how they are best applied in studying 
these protein-membrane interactions and construction of protocellular systems. We then review 
recent mechanistic insights into the function of proteins involved in the sculpting and scaffolding 
membranes gained from biophysical studies on reconstituted minimal systems. This leads us into a 
brief overview of the theory of membrane elasticity and the important additional insights of 
combining appropriate theoretical models with biophysical experiments in understanding biological 
mechanism. These biophysical insights form the basis of a discussion of how these lessons from 
nature can be best applied to the design of protocellular materials where we argue the merits of 
designing minimal machineries optimised for in vitro function and give recent examples of such 
reengineered or biomimetic nanomachines. We close with an outlook for the future development of 
nanomachines for dynamic control of compartmentalisation in engineered protocells, proposing 
how the field might proceed from biophysical insight of natural machineries to biological 
components that can be engineered into predictable protocellular machines.!
!
Setting Boundaries: In vitro model membrane systems 
A range of model membrane systems exist that are useful for the study of reconstituted proteins 
and protein complexes. These can be categorised into supported membranes, which are 
membranes that have been formed on a supporting substrate, and unsupported membranes, 
which are unconstrained membranes that are free-floating in solution. While, as we will see, 
unsupported membrane systems have the greatest capacity for encapsulation of chemical 
processes, supported membrane systems allow the application of powerful surface-analytical 
techniques to the study of protein-membrane interactions.!
 
Substrate-supported membranes 
Supported membranes can be formed upon a variety of solid substrates, with commonly used 
substrate materials including mica, gold, quartz and glass.2 These solid supports rigidly confine the 
membrane to their surface and thereby suppress the membrane’s freedom to bend in response to 
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interactions with proteins and other membrane-active matter. The attractive interactions that are 
required to exist between the membrane and its support in order for it to remain confined to its 
surface may also have other perturbations on the properties of these membranes that do not exist 
in unsupported systems. For example, changes in membrane dynamical properties are well 
known: lateral diffusion coefficients of lipids in surface supported membranes can be significantly 
slower than in unsupported model membranes.3 Furthermore, the morphology and dynamics of 
lipid domains in phase-separated membranes can exhibit significant differences between 
supported and unsupported membrane models. 4-8 Despite these possible disadvantages, surface-
supported systems are still widely used to study lipid membranes. The primary reason for this is 
the range of surface analytical techniques that allow membranes to be studied with greater 
resolution and sensitivity than is often achievable with unsupported model membranes. These 
techniques include atomic force microscopy (AFM) for high resolution topological imaging, 4,5,7,9 
AFM and surface force apparatus for measuring the mechanical forces and interaction forces of 
membranes,10 quartz crystal microbalance, 11,12 surface plasmon resonance13 and total internal 
reflection fluorescence microscopy (TIRF-M)14 for membrane binding interactions, membrane 
electrochemistry (e.g. supported membranes on gold electrodes)15 and time-of-flight secondary ion 
mass spectrometry imaging for studying the lateral distribution of chemical composition within a 
membrane.16!!
A variety of methods exist for creating substrate-supported model membranes. The most 
commonly used techniques are the vesicle fusion method, where small or large unilamellar 
vesicles, which are dispersed in an aqueous solution above the substrate, fuse with the supporting 
surface to form a single lipid bilayer, and the Langmuir-Blodgett (LB) method, where the substrate 
is passed twice through a lipid monolayer formed at an air-water interface by dipping the cleaned 
solid-surface into and out of the aqueous phase.17 Several methods have also been developed to 
create asymmetric supported lipid bilayers where each lipid monolayer has a different lipid 
composition. 18-20 This mimics the lipid asymmetry known to occur in natural membranes and 
allows characterisation of how such asymmetry modulates the physical properties and behaviour 
of the membrane.!
Due to solid membrane substrates not generally being relevant as a nature biological interface and 
their hindrance for incorporation of transmembrane proteins, softer supports have been developed. 
These include supported membranes on polymer cushions or hydrogels and membranes extended 
from the surface by “molecular stilts”: functionalised lipids such as oligoethylene glycols with a thiol 
functionality at one end for covalent surface attachment and a sterol at the other to insert into the 
hydrophobic core of the membrane. 21-25 Furthermore, techniques have been developed to create 
regions of unsupported membrane within in a supported lipid membrane by forming the bilayer 
atop a microfabricated substrate that contains small holes. The supported membrane does not 
enter these holes but rather spans the gap, providing regions of membrane that do not directly 
interact with the substrate. 26-28 Finally it should be noted that supported membranes have been 
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formed on the surface of colloidal particles; this allows the dispersion of supported membranes into 
bulk solution and introduces curvature to the membranes comparable to those found in biological 
cells and organelles. 29,30!!
 
Unsupported membranes 
Unsupported membranes allow dispersion of lipid bilayers into the aqueous phase without the 
need for a supporting substrate. Several such model systems exist; we will briefly introduce lipid 
nanodiscs, droplet interface bilayers and small, large and giant unilamellar vesicles. We will give 
most emphasis to giant unilamellar vesicles (GUVs) as these are cell-sized model membranes 
capable of encapsulating chemical processes. Furthermore GUVs are the most common model 
membrane used in the literature for reconstitution of functional protein complexes.!
 (a) Lipid nanodiscs are lipid bilayer micelles whose edge tension is stabilized by α-helical 
scaffold proteins. 31,32 Depending on the scaffold protein that is employed, these disc-like 
membrane fragments vary in diameter between approximately 10 – 18 nm with a narrow size 
distribution.33 These model membranes have primarily been employed as a more biologically 
relevant alternative to detergent solubilisation of integral membrane proteins for structural and 
functional assays. 34-36 Most relevant to the study of membrane remodelling protein complexes is 
the use of lipid nanodiscs for single molecule fluorescence spectroscopy studies.37!  Due to the 
small surface area of membrane available on a lipid nanodisc, experimental protocols can be 
designed such that only a single protein or protein complex will interact with a nanodisc. This 
scenario is much harder to achieve using model membrane systems based upon lipid vesicles, 
which have a much larger surface area per particle for interactions to take place and the number of 
interacting proteins per lipidic particle would follow a Poisson Distribution..!
(b) Droplet Interface Bilayers (DIBs) are formed using water-in-oil emulsions.38!  Water 
droplets dispersed in an oil containing dissolved lipids recruit a lipid monolayer to the oil-water 
interface. When two of these droplets are brought into contact, oil is excluded from the interfacial 
region between the droplets such that a lipid bilayer membrane forms between the two aqueous 
compartments. Electrophysiological measurements have been used to study the ion permeability 
of these membranes in the presence of intergral and peripheral membrane proteins. 39-41! 
Experimental geometries have also been developed that allow simultaneous electrophysiological 
and fluorescence microscopy studies.42! As we will see, DIBs are also a starting point for some of 
the more advanced methods for fabrication of GUV model membranes. Notably, DIBs and 
vesicles, which will be discussed below, have the capacity to compartmentalise chemical entities 
and processes within an encapsulated volume and therefore are prime for stepwise increase in 
complexity of reconstituted biological systems towards the bottom-up development of artificial cells 
and tissues. !
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(c) Small or Large Unilamellar Vesicles (SUVs or LUVs) are nanoscale or sub-
micrometer unsupported membrane shells with an encapsulated aqueous compartment 
segregated from the bulk water phase. SUVs (<100 nm diameter) are usually formed by high 
energy sonication of multilamellar vesicles (MLVs; formed by the dispersion of dried lipid films into 
an aqueous buffer by vortexing).43!  LUVs (100 – 1000 nm diameter) can be formed by several 
different methods; most commonly they are formed by multiple extrusions of MLVs through 
polycarbonate filters with monodisperse pore sizes of between 100 – 400 nm. Alternatively they 
can be formed by reverse phase evaporation or detergent extraction methods. Aqueous vesicle 
dispersions are often studied by spectroscopic or calorimetry techniques that report the statistical 
ensemble averaged behaviour of a large population of vesicles; example techniques include 
isothermal titration calorimetry, fluorescence spectroscopy, dynamic light scattering, 
electrophoretic light scattering and electron spin resonance spectroscopy. More recently 
techniques have been developed that allow single vesicle analysis of sub-micrometer vesicles, e.g. 
by anchoring these vesicles to a surface and using spatially-resolved surface analytical 
techniques.44,45!  One of the advantages of SUV and LUV systems is the ability to create 
membranes of high curvature, thus allowing systematic study of curvature-dependent effects that 
influence protein-membrane interactions. 46-48!!
(d) Giant Unilamellar Vesicles (GUVs) are vesicles that are >1 µm in diameter (most 
typically in the range of 10 – 30 µm) and so are observable by optical microscopy techniques. This 
allows experimental observations to be conducted at the single vesicle level. Beyond the average 
behaviour of a sample, single vesicle analysis can reveal the full distribution of vesicle behaviours, 
transient intermediate states and is sensitive to rare events. Due to their large size (similar to that 
of biological cells), GUV membranes have low curvature and are usually considered to be 
effectively flat for the purposes of interactions with nanoscale proteins and protein complexes. 
However methods have been developed to study curvature effects in GUVs by extruding cylindrical 
lipid tubules from the GUV surface that are a few tens of nanometers in diameter: the cylindrical 
curvature of these structures implies high curvature for only one of the two principal curvatures of 
the membrane, the second principal curvature being equal to zero. 49-51!  For high spherical 
membrane curvature (both principal curvatures are high), then SUVs or LUVs are more 
appropriate model systems.!
While optical microscopy is often used to study GUVs, GUV experimental analysis can go 
well beyond the recording of qualitative pictures, as summarised in table 1. Dense (e.g. sugar 
solutions) are often encapsulated within GUVs such that the encapsulated phase is more dense 
than the surrounding solution, causing the vesicles to sediment to the bottom of the sample dish, 
making them easier to find and observe.52!  Methods have also been developed that allow 
reconstitution of integral membrane proteins into GUV model membranes.53!!
Methods for preparation of GUVs are summarised in Figure 1. The most popular method 
for GUV production is the electroformation method. 54,55! Lipid films are dried from chloroform stock 
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solutions onto Pt wire or ITO-coated glass electrodes. After rehydration with an aqueous solution 
(often a sucrose solution), an a.c. electric field protocol is applied to the electrodes for 1-2 h. The 
initial sine wave a.c. frequency usually ranges between 10 – 20 Hz and many protocols gradually 
reduce this frequency in a stepwise fashion during the electroformation procedure. The amplitude 
of the a.c. field that is used usually varies between 1.5 – 5 V, with the lower end of this range more 
appropriate when charged lipids form part of the lipid mixture. While electroformation usually 
produces a high yield of high quality GUVs, disadvantages of this method are that high salt or high 
(~<20 mol.%) anionic lipid content significantly suppress GUV yield or prevent their formation 
altogether. However it should be noted that this techniques works very well for phospocholine-rich 
membranes, the most predominant lipid type in Eukaryotic membranes. Physiological salt buffer 
can be added to the extravesicular medium after electroformation is complete. Protocols using a 
higher frequency a.c. field have been reported that facilitate GUV formation in physiological salt 
buffers.56!  Alternatively, the gentle hydration method can be used to form GUVs, but this method 
gives a lower yield of high quality GUVs.57!  Recently formation of GUVs assisted by a polyvinyl 
alcohol gel support has been reported that permits a wide range of lipid compositions and buffer 
conditions to be used.58!!
A further disadvantage of these GUV preparation methods is the challenge of 
encapsulation of different chemical entities inside GUVs compared to those in the extra-vesicular 
aqueous solution. Upon forming the GUVs in the presence of compounds required for 
encapsulation, similar concentrations will be present inside and outside the vesicles. Separation of 
unencapsulated compounds from the sample is challenging, with tradition approaches used for 
LUVs, such as size exclusion chromatography or dialysis, proving to be inefficient. More recent 
developments in GUV fabrication methods use emulsion-based assembly protocols and allow 
more efficient specific encapsulation of compounds. Emulsion phase transfer methods are based 
on the transfer of lipid stabilized water-in-oil droplets through an oil-water interface, where it picks 
up a second lipid monolayer, resulting in formation of a completed GUV in water with encapsulated 
contents.59!  This method can also be adapted to produce asymmetric membranes.60!  Microfluidic 
lab-on-a-chip methods are being developed for GUV fabrication, in particular using flow-focussing 
droplet microfluidics geometries. 61,62!  Recently droplet microfluidics and emulsion phase transfer 
strategies have been combined into a single on-chip GUV fabrication protocol.63! Microfluidic jetting 
has also been reported using DIBs as a starting point for GUV formation; jets of fluid cause GUVs 
to break away from the DIB.64!  This method can be used for high encapsulation efficiency and 
formation of asymmetric membranes.65!  DIBs in conjunction with the emulsion phase transfer 
method have been used to create multicompartment GUVs. 66,67!!
!
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Structure translates into function for membrane-bound compartments 
The cell cytoplasm is crowded with molecules that each belong to different pathways. Membrane 
organelles organise cell content and streamline cellular functions. These membrane-bound 
compartments allow small molecules to permeate by diffusion whereas larger cargoes are 
encapsulated through remodelling of their surfaces in a process called endocytosis (figure 2). 
Phospholipid membranes provide organelles with unique morphologies that define their functions. 
Intracellular membrane organelles have highly complex shapes with a common characteristic: their 
large membrane area in comparison to the volume they enclose. Endoplasmic reticulum and Golgi 
apparatus membranes adopt typical tubulated structures, acting as storage and processing units 
for vesicular cargoes. Membrane tubules are also a feature of early endosomes, organelles that 
capture vesicles originated from endocytosed cargo and ‘mature’ into multivesicular bodies while 
moving along microtubules tracks (figure 3). While early endosomes adopt irregular structures, 
MVBs consist of vesicles inside larger vesicles that are conduits for compartmentalisation, sorting 
and transport of material to selected destinations68 (figure 3). There is a biological reason for this 
variety in organelle shape: larger surface areas facilitate cargo exchange between the intraluminal 
space of the organelle and the cytosol. Furthermore, larger surfaces allow for efficient separation 
of cargo at the membrane. This structure-function relationship existing in intracellular membrane 
compartments would ideally be translated into synthetic cellular systems to optimise their 
functional capabilities and efficiencies. So what is shaping membrane-bound compartments in 
functional biological cells?!
!
Tools for the job: in vitro reconstitution of molecular systems for sculpting 
membranes 
The complex shape of intracellular organelles is moulded by physical forces acting on phospholipid 
membrane bilayers. The mechanical tools exerting localised forces that induce membranes’ 
deformation are organised assemblies of proteins that recognise, anchor and remodel vesicular 
structures. There are two main types of membrane remodelling events: fusion and fission. Here we 
will cover some of the most recent work aimed to understand how structures of individual and 
assembled proteins drive these processes. 
Membrane fusion 
Membrane fusion occurs in a wide variety of cellular activities, especially those that involve 
endocytosis or exocytosis of material69 It has only been in the last two decades that the molecular 
machinery and mechanisms of membrane fusion have been uncovered. Molecules, or ‘cargo’ are 
constantly being moved around cellular compartments and delivered to precise intracellular 
destinations. This traffic and transport of cargoes in, out and throughout the cell occurs without 
compromising the structure of any cellular organelle thereby leaking their contents; this is achieved 
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via fission and fusion of membrane vesicles. Transport vesicles filled with cargo bud from a donor 
organelle, and are then transported to an acceptor organelle, where they dock to the membrane 
and fuse, thereby releasing their cargo (figure 3). Here we look at some of the main structural and 
mechanistic aspect of the main players in membrane fusion and targeting: SNARE complexes.!
!
SNAREs. The main molecular machinery that performs membrane fusion is a specialised set of 
coiled coil proteins called SNAREs. SNARE proteins selectively target a vesicle to its destination 
by matching up a SNARE protein on a vesicle (v-SNARE) with a corresponding SNARE protein on 
the target membrane (t-SNARE).  Vesicle fusion involves many coordinated steps, including the 
formation of a tetrameric α-helical coiled coil bundle (figure 4a). Once tethered to the membrane, 
through this t-/v- SNARE complex, the vesicle undergoes several ‘priming’ events to prepare it for 
fusion. An influx of calcium ions acts as the trigger to begin fusion. There are over 60 SNAREs 
identified in yeast and mammalian cells; found in distinct intracellular compartments throughout the 
cell and implicated in the vast majority of membrane trafficking events.70 SNAREs were first 
purified by Sollner et al71 who proposed a ‘SNARE hypothesis’ that a stoichiometric complex is 
formed consisting of anchoring and tethering v- and t-SNARE located on donor and acceptor 
membranes (figure 4b); a cytosolic accessory fusion protein SNAP and the enzyme NSF (N-
ethylmaleimide-sensitive factor) are necessary for SNAREs complex disassembly. The SNARE 
hypothesis postulates that fusion is driven by the close proximity of membranes brought about by 
the specific interaction of a certain vesicle and target SNAREs. !
The first observation of content mixing was seen using an in vitro fluorescence-based assay using 
liposomes72. This work suggested SNARE proteins form the minimum machinery required for 
fusion.  SNARE complexes are specific, as v-SNAREs do not interact with other v-SNARE 
containing liposomes or protein free vesicles. The interaction occurs via a unique hairpin-like 
structure formed by the SNARE complex, named SNAREpin, and is similar to structures formed by 
some viral fusion proteins.73 The Weber paper has been cited 1925 times since its publication in 
1998 and received much attention, not only due to the cell biology questions it answered, but also 
the prospect of studying membrane fusion in a fully reconstituted system. !
!
Assembly of a stable SNARE complex occurs spontaneously in solution when using free SNAREs 
and is energetically favourable. In cells this is controlled by a series of regulatory proteins, but can 
formation of the SNARE complex and fusion be controlled in synthetic cell systems? SNARE 
complexes can assemble before fusion and these unfused intermediates accumulate at lower 
temperatures, therefore something other than high concentrations is required to induce fusion.  It 
was noticed that prefusion ‘priming’ steps occur more slowly in a cell free system, possibly as the 
proteins need to topically rearrange themselves into a circular array to give rise to the ‘fusion pore’ 
(figure 4b) that initiates fusion74,75. Some viral proteins behave in a similar fashion, forming pre-
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fusion intermediates at low temperatures that only fuse once the temperature has increased or 
been triggered by a low pH (such as within an endosome).76 !
!
Lipid bilayer nanodiscs were used recently to demonstrate that one SNARE only is required for 
maximum rates of membrane fusion, but release of membrane contents on physiological 
timescales requires zippering of multiple SNAREs into SNAREpins structures suggesting that 
SNARE complexes prevent the fusion pore from resealing during cargo release.77 SNARE-driven 
fusion in liposomes occurs at rates comparable to physiological fusion following removal of an 
inhibitory N-terminal domain in t-SNAREs, without affecting the rate of the v- t- SNARE complex 
formation itself. Full length v-/t- SNARE reconstituted liposomes in the presence of Ca2+ also 
enables membrane fusion at near physiological rate –confirming the role of Ca2+ as a regulatory 
factor in fusion.78!
!
The size of the lipid vesicles and the lipid composition itself may also affect the efficiency of fusion. 
For instance, recently we have learned that for physiological concentrations of SNARE proteins to 
perform efficient membrane fusion there is a specific requirement for small neutral lipids that do not 
form bilayer structures (i.e., phosphatidylethanolamine). In the absence of these types of lipids, 
vesicles can still dock and form trans-SNARE complexes but cannot remodel membranes for 
fusion. 79!
!
Although it is expected that in a synthetic system with minimal machinery that fusion would occur 
more slowly than in vivo and reasonable to conclude that other absent components could facilitate 
fusion, for example SNAP and NSF. NSF, stimulated by SNAPs, use ATP hydrolysis to dissociate 
the stable SNARE complex and seem to allow further rounds of fusion to occur.  The possibility 
remains that they also act to regulate fusion, potentially through the inhibitory N-terminal domain of 
t-SNAREs. It is generally agreed that fusion occurs through a fusion pore, more recently termed a 
‘porosome’, whereby several SNARE complexes form at the site where fusion is to take place and 
arrange themselves into a ring structure giving the membrane a dimpled appearance.80 The 
detailed structure of porosomes has been revealed using reconstituted fusion pores in large 
unilamellar lipid vesicles (LUVs) and examined by transmission electron microscopy (TEM). This 
work revealed a basket-shaped morphology with a SNARE complex ring at the base of the fusion 
pore and also that the porosome was still functional.81   !
!
Measurement of content mixing of large biomolecules within vesicles can be elegantly performed 
by incorporation of fluorescently labelled DNA hairpins inside vesicles. Using FRET to quantify real 
fusion events, a decrease in FRET signal would occur when a labelled DNA strand encounters a 
complementary strand from another vesicle. 82 This approach discounted instances of vesicle 
aggregation or vesicle rupture, which can obscure actual membrane fusion, and allows a highly 
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reliable method for detecting fusion. Adopting this method showed that SNARE complex alone is 
the minimal machinery required for fusion pore formation and expansion (large enough to allow 
cargo transfer up to 11kDa). !
!
An interesting characteristic of SNARE proteins is their preference for phase-separated lipid 
bilayers, or lipid ‘rafts’, as it was suggested from in vivo work showing SNAREs’ preference for 
cholesterol-rich regions. Lipid rafts represent liquid-ordered regions of the membrane, rich in 
saturated lipids and cholesterol, which act as platforms for an array of interactions concerned with 
protein intracellular trafficking. These micro-regions are more ordered and tightly packed than the 
surrounding bilayer, but are largely inaccessible to direct observation in vivo. However, it was 
found that SNAREs in fact have a higher affinity for liquid-disordered regions of membrane83 as 
demonstrated by monitoring the localisation of  fluorescently-labeled SNAREs reconstituted in 
phase separated GUVs.   
 
Intriguingly, enveloped viruses also use membrane fusion machineries to enter a cell. These 
machineries are functionally similar to, but mechanistically distinct from the SNAREs. In analogy to 
SNAREs, coiled-coil structures are pivotal in the fusion mechanism of many viral proteins, and the 
formation of a low energy membrane structure via the fusion pore. Typical examples are gp41, a 
protein that adopts a functional six helix bundle allowing HIV-1 fusion with the cell membrane84, 
and influenza hemagglutinin, which undergo pH-driven conformational change to form a fusion-
competent coiled coil trimer.85 It has been common to study the membrane interaction of viral 
fusion peptide fragments in reconstituted systems to demonstrate the mechanistic diversity 
between different viral fusion machineries.86,87 However, an example of functional reconstitution of 
a full fusion protein has been reported with the assembly of the full GPC envelope glycoprotein of 
Hemorrhagic-Fever Arenavirus into proteoliposomes. In this study, pH-dependent fusion was 
demonstrated using fluorescence lipid-mixing and content-mixing assays.88 
Membrane bending and fission 
Membrane fission shares some similarities with fusion, such as the formation of a pore-like 
structure, and the ability to overcome the energetically unfavourable process of membrane 
bending. During fission, vesicle budding occurs either away from or into the original cellular 
compartment. Frolov et al have recently presented an excellent review on the geometry of 
fission.89 Membrane fission is a multistep process that requires the action by key proteins that 
initiate the process through membrane deformation. Well-studied examples of proteins that 
remodel the membrane to induce or aid fission are BAR and ENTH domains, and the ESCRT 
machinery. Protein assembly on the inner or the outer part of membrane compartments dictate the 
topology of fission. There are few characterised mechanisms that promote membrane deformation 
prior to fission (figure 5). Some protein modules mediate fission by shaping the exterior of a 
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nascent budded vesicle like clathrin, and COPI coats, and oligomerised proteins containing ENTH 
and BAR domains. A different approach is instead used by ESCRT complexes, which assemble on 
what will become the interior surface of the lipid bilayer delimiting a vesicle. For this reason, 
ESCRT complexes can also participate in processes such as cell division, performing the last step 
of fission of the plasma membrane. 90!
!
BAR and ENTH domains. BAR domain-containing proteins (Bin-Amphiphysin-Rvs) are curvature-
sensing α-helical proteins that oligomerise to induce further bending in membranes. The overall 
topology of BAR domains resembles a banana shape (figure 6a), however there are several 
subtypes of BAR domains, that recognise, induce and stabilise different degrees of curvatures.91 
Each BAR domain’s subtype is characterised by a curved structure specifying if either positive 
(BAR, N-BAR and F-BAR) or negative curvature (I-BAR) is introduced in a flat membrane. Binding 
of BAR domains to membranes occurs through specific interaction with lipids and further 
classification of BAR domains can be done to reflect their mode of interaction with membranes. For 
instance, F-BAR and BAR yeast proteins involved in endocytosis show different lipid binding 
preference when tested in an in vitro system. 92 The yeast BAR domain-containing protein 
Rvs161/167 preferentially binds to phosphatidylinositol 4, 5-bisphosphate (PI(4,5)P2), PI(3,4,5)P3 
and PI(3)P showing that the affinity towards lipids increases with additional phosphate groups i.e. 
PI(3,4,5)P3>PI(4,5)P2>PI(3)P. In contrast, membrane binding affinity does not seem to be affected 
for F-BAR-containing proteins by phospholipids’ structure – in fact Syp1 was even slightly inhibited 
by dense regions of PI(4,5)P2. Time-lapse imaging of GUVs incubated with the F-BAR domain of 
Syp1 and the BAR domain of Rvs161/167 showed how Rvs161/167 efficiently can replace Syp1 
on the surface of GUVs containing PI(4,5)P2. The curvature-sensing mechanism for BAR and F-
BAR domains also seems to differ in that BAR domains rely on insertion of an amphipatic α-helix 
into the hydrophobic region of the lipid bilayer (as in the case for Rvs161/167), whereas F-BAR 
proteins (Syp1 and Bzz1) sense curvature using a much shallower insertion into the bilayer, and 
eventually induce bending via ‘protein crowding’. Protein crowding causes local membrane 
bending via the high lateral pressure that occurs between proteins sitting closely on a membrane.93 
Such crowding, in addition to helix insertion,94 can induce significant asymmetry in the 
spontaneous curvature of each leaflet of the bilayer, driving the membrane to bend. Furthermore, a 
recent combined simulation and transmission electron microscopy study of high-density BAR 
domain interactions suggests excess adhesive energy combined with local stiffening of the 
membrane contribute to curvature-driven morphology changes that can ultimately transform 
spherical vesicles into tubular networks.95!
!
During BAR domains interactions with the membrane, lipid clustering can occur. 92 The idea of 
proteins preferentially binding to liquid ordered phases, namely ‘lipid rafts’, was previously explored 
in experiments conducted with SNAREs. Phophoinositide-clustering is an effect observed for 
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mammalian I-BAR domains 96 but is also displayed by BAR and F-BAR domains, which effectively 
‘freeze’ the dynamics of phosphoinositides and in turn whole regions of the membrane rich in these 
acidic lipids. The link between sensing curvature and inducing bending in membranes was an 
active role was proposed for protein density. 97 It is possible to create an environment where 
membrane tension, curvature and protein density can be systematically controlled, using GUVs as 
a membrane model system. Optical tweezers can be used to create nanotubes with different 
shape and sizes by pulling of membranes from GUVs. Protein density at the GUV surface and 
tubules can be measured by fluorescence, whereas the pulling force and tube radius gives a 
measure of curvature and tension. The radius of the tubules is directly proportional to membrane 
tension in the GUV. When the interaction of amphiphysin (an N-BAR protein enriched at clathrin 
coated necks during endocytosis) with membranes is analysed vs. degree of curvature and 
tension, simultaneous roles of BAR proteins as curvature sensors and inducers is revealed.50 For 
instance, low densities of amphiphysin sense but do not significantly induce curvature. At high 
densities, amphiphysin strongly deforms membranes via the formation of a scaffold (figure 6b). 
Similar behaviour was also observed previously for dynamin, a GTPase involved in membrane 
fission and for endophilin, an endocytic protein enriched at neural synapses. 98 99 !
!
Some BAR domain containing proteins can be regulated by autoinhibition such in the case of 
pacsin. Pacsin is a F-BAR protein found primarily in neurons that can be studied in vitro using 
liposomes enriched with Folch lipids (a type of lipid found primarily in brain tissue for signalling).  
The interaction between pacsin and dynamin (an F-BAR containing protein) demonstrated how 
different BAR domain-containing proteins can efficiently regulate each other. It has been shown 
that pacsin exists in an autoinhibited state in vitro and in vivo. 100 Full length pacsin binds with less 
affinity to the membrane than its F-BAR domain alone and also prefers less curved surfaces. In 
comparison, endophilin, an N-BAR protein does not show any significant difference in membrane 
deformation activity between full-length endophilin and its N-BAR domain alone. This evidence 
suggests that N-BAR proteins may induce curvature by a different mechanism to F-BAR proteins, 
possibly such as protein insertion and that relieving F-BAR proteins autoinhibition is a mechanism 
to regulate membrane deformation.!
 
In contrast to BAR domains, ENTH domain structures are not naturally curved but utilise an N-
terminal amphipathic helix to ‘wedge’ into membranes promoting deformation and even tubulation 
at high concentrations. Epsin NH2-terminal homology (ENTH) domain is a membrane-binding motif 
first identified in the endocytotic protein, epsin. The ENTH domain can bind to certain acidic lipids, 
particularly phospholipids, including PI(4,5)P2 and PI(1,4,5)P3. ENTH-domain proteins are 
involved in clathrin-mediated membrane budding, whereby a clathrin protein coat forms around 
budding vesicles. In particular, ENTH proteins can recruit clathrin adaptors to the site of membrane 
budding enabling regulation and organization of clathrin on membranes. In vitro, isolated ENTH 
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domains promote fission of vesicles when added to lipid bilayers but cannot act in concert like BAR 
domains and facilitate membrane fission generated by dynamin. 101.!
!
ESCRT complexes. Sequestering of transmembrane growth factor receptors is how a cell 
regulates its survival. The multivesicular body (MVB) pathway is the main membrane transport 
system that is responsible for transmembrane cargo recycling or degradation. The endosomal 
sorting complexes required for transport (ESCRT) complex is a set of evolutionally conserved 
proteins involved in fission events that drive the ‘maturation’ of MVBs from early endosomes. The 
MVB represents a large membrane-delimited container filled with cargo-loaded intraluminal 
vesicles (figure 3). In contrast to other budding mechanisms, generation of MVB is a process 
where membrane deformation occurs away from the cytosol. !
!
The ESCRT machinery consists of four distinct complexes generally acting in sequential 
mechanism. ESCRT-0 and ESCRT-I perform specific cargo recognition and concentration at sites 
of MVB intraluminal vesicle formation, whereas ESCRT-II interacts with and anchors to acidic lipids 
in the endosomal membrane allowing ESCRT-III to form an organised structure on the membrane 
surface at the site of fission and initiate budding102 (figure 7). ESCRT-III is the core membrane 
scission machinery that performs membrane fission. It creates filamentous circular arrays from 
polymerisation of its subunits, delineating spirals narrowing in size and ultimately generating 
variable size necks for nascent vesicles. 103!
!
Much is known about the structure of the filament array of ESCRTs and how they sequester cargo 
into intraluminal vesicles, however it is only recently that reconstitution of MVB formation has been 
successfully reproduced. Elegant work using GUVs demonstrated a coordinated assembly of 
ESCRT complexes on phospholipid capable of inducing a region of negative curvature that initiates 
budding and stabilises the neck of a nascent vesicle. Ultimately, narrowing of the vesicle neck by 
gradual disassembly of the complex drives intraluminal vesicle fission. In analogy to BAR domains, 
ESCRT-III proteins exist in an autoinhibited state, which has to be released for initiating complex 
assembly. The enzyme VPS4 provides the mechano-chemical force necessary to activate ESCRT-
III for assembly on the endosomal membrane, disassembly of the complex and ultimately recycling 
ESCRT subunits, returning them in the monomeric inhibited state. This assembly-disassembly 
cycle allows for further rounds of fission to occur thereby generating continuous cargo 
encapsulation. 104-106  
 
So far, we can only predict via computational modelling how ESCRT-III polymers generate inward 
budding in membranes. In the ‘dome’ model, ESCRT-III polymers assembled into a three-
dimensional spiral define the necks of a nascent vesicle and provide the physical force to push the 
membrane.107 In the ‘coatless’ model, ESCRT complexes localise only at the neck region of 
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nascent membrane buds and bend membrane aided by inducing lateral lipid phase separation. 108-
110 Intriguingly, the high redundancy of ESCRT-III in Nature suggests that varying the content of 
different ESCRT-III subunits may give origins to different polymeric structures111, possibly 
generating vesicles of different sizes. !
!
Supporting membrane structure and dynamics 
Changes in cell shape control fundamental processes such as cell division and cell motility.  
Building cells from scratch or creating transport systems mimicking cellular structures requires 
reconstitution of an organised cytoskeleton interacting with a membrane. Here we will review some 
of the reconstitution studies of cytoskeletal components for the purpose of investigating the 
mechanisms of membrane shaping.!
Keeping in shape and keeping active: the role of cytoskeleton in membrane deformation 
The cytoskeleton provides membrane structures with shape control through mechanical 
modulation of networks of filamentous protein polymers. The major players in cellular shape 
change are the actin cytoskeleton that dynamically changes membrane morphology, and tubulin, 
which following polymerisation, supplies the tracks onto which membrane vesicles transport cargo 
across a larger organelle. Actin filamentous networks provide the necessary membrane tension for 
shaping membranes into protrusions and invaginations or simply to provide a framework for 
stability. Furthermore microtubules and actin filaments display directionality of polymerisation, a 
property conferred by their coupling to molecular motors.  
 
Experimental approaches employing supported lipid bilayers and liposomes have helped to shed 
light on the mechanism of membrane shaping through actin polymerisation.  An increasing number 
of in vitro studies have demonstrated how to successfully reconstitute actin networks inside and 
outside liposomes112  or on lipid bilayers.113 A reconstituted actin cytoskeleton can be coupled to a 
vesicle’s interior to provide mechanical shape and stability to the membrane compartment. For 
instance, spectrin, a cytoskeletal protein component of erythroid cells, can be reconstituted as a 
shell at the outer membrane of GUVs by addition of ATP, providing a rigid framework for vesicle 
shape.114 Co-encapsulation of myosin motors with actin filaments induces contraction of the 
meshwork, ultimately reproducing membrane contractility.115 In vitro reconstitution studies of actin 
shells anchored outside or inside liposomes has revealed how the strength of anchoring to 
membranes controls cortical actin remodelling,116 providing a simple model for polarity of actin 
shells and mechanistic basis for a cell’s movement. When actin layers are assembled and 
anchored outside liposomes, the action of molecular motors generates cortical tension, which 
results in opposite effects on the membranes. High tension causes cortical actin to retract to one 
side of the liposome, whereas low tension coupled with strong anchoring between actin and 
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membranes, results in vesicles shrinkage. In a model where an actin shell is assembled and 
anchored inside liposome vesicles, actomyosin filaments retract away from the membrane if the 
strength of anchoring is weak, whereas they are pulled towards the membrane when the 
attachment of the cortex is strong.   
 
The cytoskeleton is also crucial for facilitating membrane scission in cell division events. For 
instance, a reconstituted minimal complex of a bacterial homologue of tubulin (FtsZ), and a single 
accessory protein (FtsA) has been shown to be competent for cell division when incorporated into 
liposome vesicles. 117 The beautiful simplicity of the bacterial division machinery demonstrates that 
the main requirement for membrane severing is an organised assembly of proteins, without the 
need for excess membrane. 
 
However, cytoskeletal cortices do not only play an active role in moulding a cell’s plasma 
membrane but they define shape changes of intracellular membrane compartments. Membrane 
tubulation is an event initiated either by proteins that can scaffold positive membrane curvature 
(such as COPI or BAR proteins), or generated by the pulling forces of molecular motors attached 
to localised regions of the organelle’s membrane. Growth and retraction of membrane tubules from 
larger organelles is another mean of cargo transport in the membrane trafficking system of a cell, 
in addition to vesicles. This dynamic motion of tubular structures is due to the presence of 
molecular motors that can walk along the fast growing tip of cytoskeletal microtubules (plus end 
motors, e.g. kinesins) or in the opposite direction (minus end motors, e.g. dyneins). Reconstitution 
of membrane tubule ‘pulling’ processes has been reproduced using both cell extracts and minimal 
components.118 An alternative means to generate tubulation is to ‘push’ from the inside of a 
vesicle. Encapsulated microtubule components can create long protrusions when polymerisation is 
induced.119!
!
Curvaceous Models: Membrane Elasticity Theory 
Theoretical modeling combined with in vitro model systems is a powerful tool to characterise and 
quantify the physical properties of the protein components of this membrane remodelling toolbox. 
When the proteins or protein complexes reviewed above interact with membranes, they generate 
changes in the shape or structure of the membrane interface. Theoretical models to understand 
these processes usually use the Helfrich Hamiltonian.120!  This is a phenomenological model for 
membrane elasticity proposed by Wolfgang Helfrich in 1973.121! The membrane is treated using a 
continuum model where the lipid bilayer is considered to be a fluid elastic sheet, i.e., the molecular 
scale details of the membrane structure are averaged out into bulk mechanical properties of the 
bilayer that determine its behaviour. This model also assumes that the membrane is a thin sheet 
such that the thickness of the membrane is very small compared to the lateral extent of the 
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membrane surface. The Helfrich Hamiltonian (!!∀#∃%&∋) describes the elastic contribution (per unit 
area) to the free energy of the membrane,!
!!∀#∃%&∋ ! !!∀#∃ ! !!∀#∃∀%!  (1)!
!
where !!∀#∃ is the free energy per unit area due to membrane bending and !!∀#∃∀%! is the free 
energy per unit area due to membrane stretching. 
!
The stretching term !!∀#∃∀%! ! !, where ! is the surface tension of the membrane. This term is often 
neglected as the energy cost of stretching a lipid membrane is much greater than that of bending 
the membrane. Therefore, in many cases the stretching of the membrane is not considered to be 
significant. Membrane stretching can also be described by an elastic area expansion modulus (!!), 
where the change in free energy upon stretching the membrane! !!!∀#∃∀%! ! !!!!!∀#∃∀%! !
!! ! !! !!
!, where !! is the change in membrane area and !! is the initial membrane area. !
Typical values for !! for lipid membranes have been found to be in the range 0.1 – 0.2 J m
-2, or 25 
– 50 !!!!nm
!!.122!  It should be noted that lipid membranes are not particularly stable under 
stretching deformations; they rupture upon fractional area increases (!! !!) between 2 – 5 %.
123-
125 
!
The bending contribution to the free energy of a membrane is therefore the most significant. This 
can be described by two mechanical moduli:!
!!∀#∃ !
!!
!
!!! ! !!!
!
! !!!  (2)!
where !! is the bending modulus and !! is the Gaussian curvature modulus. H represents the 
mean curvature of the membrane, which is the mean of the two principal curvatures (!!; ! ! !!!), 
! ! !! ! !! !. G represents the Gaussian curvature of the membrane, which is also defined by 
the principal curvatures, ! ! !!!!. Finally, !! is the spontaneous or preferred curvature of the 
membrane; this is the curvature that the membrane adopts in its relaxed state and is the minimum 
curvature energy state of the membrane. It should be noted that these are the first two terms in an 
infinite expansion in H2 and G, where the higher order terms in these variables are assumed to be 
small. Therefore this model is most accurate for small bending deformations about the equilibrium 
membrane shape. Higher order mechanical moduli, e.g. for terms in H4 and G2, have not been 
determined experimentally, therefore this model is also often applied to model systems where the 
bending deformation is large.!
It has been shown that values for the Gaussian modulus !! are constrained by the bending 
modulus !! such that !! ! !! !! ! !.
7 !! is challenging to determine directly from experiments, 
but the few experimental studies of !! in amphiphile systems have found that !! ! !!!!!!. 
126,127
! 
Conveniently, due to the Gauss-Bonnet theorem, the Gaussian curvature term in equation 2 only 
contributes to the change in free energy of the system if the membrane undergoes a topological 
! 19 
transition (e.g. fusion, fission, poration). The Gaussian elasticity term can therefore be ignored for 
bending of a membrane of fixed topology, i.e. when only considering the membrane bending 
capabilities of these proteins, prior to scission, merger or poration events that may occur later in 
the membrane remodelling process.!
Equation 2 can also often be further simplified due to the fact that the lipid composition of the 
membrane is symmetric across the membrane for almost all experimental model membrane 
systems. When topological changes in the membrane do occur, it is often useful to treat the elastic 
energies of the two lipid monolayers of the membrane separately with a finite spontaneous 
curvature, !!. However for bending at fixed topology, the elastic energy of the whole lipid bilayer is 
considered together and due to the symmetry of the lipid composition in each monolayer, !! ! !. 
Therefore the total free energy of model membranes for bending at fixed topology can be simplified 
to!
!!∀#∃%&∋ ! !!∀#∃%&! d! ! !!! !
! d!  (3)!
!
where typical values of !! for lipid bilayers are in the range 10 – 20 !!!.
122
! Yet it should be noted 
that the situation is not always so simple. This model is most appropriate for membranes 
composed of a single lipid type. For model membranes composed of lipid mixtures, curvature 
dependent demixing of different lipids can occur, increasing the complexity of theoretical 
analysis.128! Indeed, variations in lipid compositions between different organelles are thought to be 
highly significant in determining the different membrane morphologies and topologies of these 
structures. 129-131!  Beyond the simplest implementations of this curvature elasticity model, 
mesoscale computational modelling approaches are often used to investigate curvature effects 
during protein-membrane interactions. 132,133!
An example of the application of theoretical models is the modelling of the interaction of F-BAR 
domains with lipid membranes.134 Combining simulations and membrane elasticity theory predicts 
an initial binding energy of an F-BAR dimer to the membrane of 4 !!!, which reduces to 2.3 !!! at 
equilibrium during membrane tubulation. Therefore this shows that single F-BAR dimers at low 
density on a membrane would not individually be able to generate enough energy to bend a 
membrane with a bending modulus of 20 !!!. Multiple F-BAR dimers would be required to act in 
concert at high density on a membrane in order to manipulate its curvature, in agreement with 
experimental observations reviewed above.  
Ultimately, it should be noted that although the Helfrich model considers the membrane to be a 
continuous sheet with no molecular details. However, the membrane mechanical moduli in this 
model can be directly related to the intermolecular interactions between lipids by considering the 
lateral stress profile in the membrane. 135,136!  This can allow consideration of protein-induced 
changes in the mechanical moduli of membranes due to the ways in which proteins modulate the 
interactions between lipids, for example by direct insertion of part of the protein complex into the 
membrane.137!!
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Finally, it is worth highlighting that computational studies have also proved an extremely practical 
tool to provide suggestive insights into the molecular-scale mechanisms of membrane remodelling 
processes, and interactions between membranes and protein complexes. While the focus of this 
perspective is the in vitro reconstitution of membrane remodelling machineries, there is a wealth of 
literature in which computer simulation approaches have provided new mechanistic ideas 
impossible to gather by traditional experimental work. In addition to the work on the F-BAR domain 
discussed above, important contributions to the possible molecular mechanisms underlying 
membrane remodelling include simulations of the membrane interactions of N-BAR domains138,139 
and SNARE proteins. 140,141 
!
Rationalisation of the toolbox for membrane remodelling 
If natural protein components are to be used as tools to generate new functional synthetic cell-like 
materials, they will need to be easy to handle and compatible with other components when 
incorporated into more complex systems. It would be highly challenging to engineer synthetic cells 
from component parts that were not well characterised and simplified machineries. The highly 
elaborate nature of many of these natural protein complexes is designed for optimal function in 
complex in vivo cellular environments. This complexity is unlikely to be required when protein 
complexes are used as parts within minimal in vitro systems. There are two possible approaches 
to developing simplified minimal components for an in vitro membrane remodelling toolbox: (i) to 
use protein engineering to redesign the proteins as minimal systems without additional, redundant 
functionality; (ii) to take inspiration from the function of these proteins to design novel, synthetic 
components that perform the required in vitro tasks. Little work has been done to establish such 
minimal machineries but examples of success in this approach will be given below.!
!
Looking to the future: is the design of minimal systems for moulding membranes possible? 
Minimal protein-based systems acting upon membranes are surely useful to investigate 
mechanisms of membrane remodelling but they also provide us with a framework for extracting 
basic design rules for function, which can then be employed for creating reduced systems. To 
date, several protein complexes have been simplified or even de novo designed for membrane 
fusion, fission and vesicle transport. The SNARE system for membrane fusion is certainly the most 
amenable to reproduction. SNAREs function on a simple principle: bringing membrane bilayers 
into close physical proximity by means of formation of an extremely stable protein complex. 
Bioinspired systems based on this principle have been created by de novo designing a minimal 
SNARE pair from complementary coiled coil peptides.  The reduced SNARE system for membrane 
fusion is based on a simple heterodimeric coiled coil pair and has been subsequently refined by 
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including moieties for membrane anchoring. 142,143 Intriguingly, most protein complexes involved in 
membrane remodelling are held together by coiled coil interactions. For instance, the structural 
features of BAR domains are arrays of anti-parallel α-helical coiled-coils adopting curved shapes 
and using a positively charged surface to interact with lipids. The extensive knowledge we have 
acquired in the area of coiled coil design,144,145 including the computational-guided de novo design 
of protein assembly curvature, 146 make the engineering of functional membrane sculpting systems 
more achievable. Coiled coil modules have already been extensively used as cytoskeleton 
biomimicry147 and recently, have been designed to self-assemble into organised cages resembling 
the structure of clathrin coats. 148,149 It is not too far fetched to think that soon we could use these 
systems to design de novo membrane remodelling tools from the bottom up.!
 
Engineering of a minimal machinery that performs membrane fission in a controllable manner is 
however challenging. Any curvature-inducing protein system can eventually promote membrane 
fission at high densities. However, the creation of new vesicles in a controlled manner requires a 
multistep mechanism including factors to induce initial membrane bending (Clathrin and COPI 
coats and even actin filaments), entities to stabilise and promote further budding (BAR and ENTH 
domain-containing proteins) and regulatory factors that promote membrane fission mechanically-
driven by nucleotide hydrolysis (dynamin). Since the development of the PURE system for in vitro 
protein expression, assembling a minimal machinery to recreate cell division using model 
membranes has moved a step closer. In situ expression of membrane deforming proteins using 
the PURE system has been shown to produce extensive membrane deformation in liposomes 
preparations upon the activity of expressed N-BAR domains. 150 !
!
Initiation of membrane scission in a model vesicle, for mimicking a dividing cell, is a process that 
must begin from the lumen of the vesicle and requires proteins that can generate narrow necks 
and induce negative curvature, such as I-BAR proteins or ESCRT complexes. In situ expression of 
minimal ESCRT machineries inside GUVs or liposomes could be the first step towards recreating 
membrane-bound compartments competent for cell division. The drawback of using complexes 
such as ESCRTs is the high redundancy of the functional assembly, making reconstitution of such 
a system for large scale production (e.g. for biotechnology applications) challenging. Monocellular 
ancient organisms such as archea bacteria, for instance, utilise ESCRT complexes with a reduced 
number of components in comparison to yeast or humans, given their simpler metabolism. These 
ESCRTs modules can be regarded as a sources or an inspiration for assembly of ‘divisomes’ or 
remodelling of membranes with appropriate lipid composition is employed. 151 !
!
Interesting developments in the design of minimal vesicular transport systems include coupling of 
liposomes to molecular motors capable of walking on molecular tracks. Liposomes coated with 
bundled actin have been used to build simple transport systems based on myosin motors. 
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152,153Complementary DNA strands are an efficient manner to anchor membrane vesicles to a 
kinesin molecule gliding on microtubules.154 In such system, loading, transport and unloading of 
fluorescent cargo-loaded liposomes can be reproduced using a flow-cell - tuning of the strength of 
binding between the DNA strands allows for vesicle unloading. Alternatively, coupling of cargo 
vesicles can be achieved via streptavidin-biotin linkage and quantum dots coupled to the trailing 
ends of actomyosin filaments via capping proteins.155 !
!
Inspired by the function of natural proteins, several synthetic alternatives have been shown to 
mimic properties of these proteins at lipid biomembranes. DNA nanotechnology is proving to be 
one useful tool in this approach.156 DNA-lipid conjugates have been successfully applied to mimic 
SNARE fusion proteins, membrane adhesion receptors, tetherins and transmembrane pores.157-160 
161 Supramolecular chemistry has also provided synthetic organic  macromolecules that can, for 
example, trigger membrane adhesion or poration. 162,163 Synthetic nanoparticles may also prove 
useful mimics of membrane remodeling proteins in minimal systems. While much of the existing 
work on nanoparticle-membrane interactions was not motivated by biomimicry of natural 
membrane-active proteins, nanoparticles have been shown to be able to bend and scaffold the 
membranes of GUVs.164-167!
!
Outlook: towards engineering functional protocells with minimal machineries 
!
We have reviewed examples of the successful in vitro reconstitution of membrane remodeling 
protein complexes and shown how these minimal systems have provided new insight into their in 
vivo biological properties and functions and their regulation by other proteins. However towards the 
higher goal of using biological components to build synthetic cell-like materials, much progress 
needs to be made. Relatively few examples exist of successful engineering of minimal membrane 
remodeling machineries more suited to optimal function within model membrane systems. Further 
efforts are required to generate a toolbox of these specialised in vitro components. To the best of 
our knowledge, no work has been reported that successfully combines two or more of these 
minimal membrane machineries into a single system; compatibility of these components may 
prove challenging in order to mitigate mutual interference of membrane interactions and function. 
Furthermore it would be of interest to demonstrate an increase in the complexity of these 
reconstituted minimal systems through coupling membrane remodelling processes with other 
functional biomolecular modules, such as mechanosensitive proteins and channels. 168,169!
In order to develop advanced minimal cells by bottom-up assembly techniques that incorporate 
scaffolding, shaping and membrane vesicle trafficking capabilities, we suggest that a process of 
development described in figure 8 should be followed. Firstly, the components need to be 
characterised using biophysical investigative approaches. These components then need to be 
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stripped back to minimal functional entities to provide maximum simplicity in their design and 
function. This process will require multiple iterations between protein complex redesign and 
biophysical characterisation. Thirdly, two or more independent membrane-active components need 
to be successfully reconstituted into model systems to demonstrate mutual compatibility and 
minimise unwanted interference between individual components. This will require the simplified, 
minimal components to behave in a predictable manner in how they interface with other 
components of the synthetic biology toolbox when combined together in systems of increasing 
complexity. Finally, incorporating metabolic processes within the compartments of synthetic cells 
can further increase complexity and functionality.!
!
Nature shows us how control of dynamic chemical compartmentalisation is required to regulate a 
large number of parallel processes within composite cellular systems; an important feature that 
synthetic biologists will wish to harness and exploit. The pathway to realising functional cell-like 
materials has become much clearer over the past 5-10 years with many significant advances in the 
understanding, design and application of in vitro model membrane-protein interaction systems. 
Now the next steps need to be taken in establishing minimal standardised parts and tools to 
generate compartmentalisation, and show that they can be successfully incorporated into 
organised functional multicomponent systems of increasing complexity. 
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Footnotes 
¶ Synthetic biology is defined as “a) the design and construction of new biological parts, devices 
and systems and b) the re-design of existing natural biological systems for useful purposes.”!
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Table 1. Overview of some of the experimental techniques used to study GUV membranes, 
including many quantitative microscopy measurements. 
 
Figure 1. Overview of some of the GUV formation methods. (a) electroformation; (b) emulsion-
transfer method; (c) microfluidic double emulsions; (d) microfluidic jetting. 
 
Figure 2. Key cellular events that require membrane fission and fusion. Membrane fission is 
typical of events such as endocytosis. It is necessary for the generation of transport vesicles, 
which fuse with sorting stations, namely the endosomes and the multivesicular bodies. Membrane 
fusion events are typical of exocytosis processes, such viral budding, the release of exosomal 
vesicles (MVBs fuse back with the plasma membrane releasing their intra-luminal vesicles), and 
MVBs merging with lysosomes. 
 
Figure 3. Cellular fission and fusion events in trafficking of cargo via membrane 
compartments. Endocytosed cargo is enveloped in clathrin coated vesicles (red), with the aid of 
fission proteins (BAR and ENTH domains). Clathrin-coated vesicles are incorporated into early 
endosomal structures. The tubules of endosome membranes are shaped by molecular motors 
(kinesin, dynein), while moving along microtubule (blue arrows) towards the centre of the cell. 
Some vesicular cargo will also be recycled to the cell surface. During movement, the endosomes 
‘mature’ into multivesicular bodies (MVB), changing their shape and protein composition (yellow 
area). MVBs are generated by accumulation of cargo destined for degradation by the lysosome 
(pink area) via membrane budding and scission events performed by the ESCRT complexes. The 
trans-Golgi network (TGN) is another sorting station for vesicular cargo that utilises COPI protein 
coats for membrane scaffolding. This figure is a derivative of figure 1 from reference 68, used 
under CC BY 3.0 licence. 
 
Figure 4.  Mechanism of membrane fusion and fission by SNARE complexes. (a) 
Crystallographic structure of an assembled neuronal SNARE complex involved in synaptic 
exocytosis (pdb code 1SFC). (b) Complementary v- and t-SNARE coiled coil structures sitting on 
donor vesicle and target membranes ‘zipper’ to bring the bilayers closer and initiate ‘fusion pore’ 
formation. The individual α-helical coiled coil chains and the respective cartoons representations 
are identically colour coded. 
 
Figure 5. Membrane remodelling proteins use various methods in order to generate 
curvature. During protein insertion, hydrophobic protein domains asymmetrically inserted in the 
lipid bilayer generate membrane curvature; this is a mechanism used by some BAR proteins. In 
protein crowding, it is assumed that the energy for membrane deformation is generated by 
collisions between proteins in close proximity on the surface. This mechanism of membrane 
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deformation is possibly used by BAR and ENTH proteins in addition to insertion into bilayers. 
Protein shape defines a mechanism where membrane bending is generated by curved shaped 
proteins with lipid binding domains, such as clathrin and COPI coats. Regions of negative and 
positive curvature are indicated (blue). Last, in protein scaffolding, membrane curvature is 
generated by assembling an organised protein scaffold or ‘lattice’ structure. Membrane 
deformation can occur where components of the scaffold are anchored to the membrane through 
protein-lipid interactions or as shown by adaptor proteins (green); this method used by ESCRT 
proteins. 
 
Figure 6.  Mechanism of membrane fusion and fission by BAR domains (a) structure of the N-
BAR domain of hBRAP1 showing the curved shape of the dimer (pdb code 4I1Q). (b) BAR domain 
sensing membrane curvature through its structure and shaping further bending via oligomerisation. 
The colour coding of protein chains represented by the crystallographic structures is identical to 
colour coding used for the protein subunits in the cartoon representations. 
 
Figure 7. Generation of intraluminal vesicular compartments by the core ESCRT membrane 
scission machinery. (I) Initial membrane bending by ESCRT-II (green cylinders) and seeding of 
ESCRT-III assembly. (II) The subunit Vps20 (red triangle) initiates Snf7 polymerization and 
ESCRT-III propagation into a filament (blue beaded assembly). The three-dimensional spiral 
topology of ESCRT-III induces further membrane invagination. A capping subunit (purple cube, 
Vps24) stops filament elongation. (III) Neck constriction and scission of the intraluminal budded 
vesicle occurs via Vps4-mediated ESCRT-III polymer disassembly. The ATPase Vps4 binds the 
ESCRT-III filament via the anchor subunit (Vps2, golden bead) (IV) Full ESCRT-III disassembly in 
preparation for a second round of intraluminal vesicle formation (ILV). 
 
Figure 8. The iterative process in the design of a minimal toolbox for membrane remodelling. 
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Table 1 
!
Measurement Technique Brief description and comments Key and 
example 
references 
Membrane 
morphology 
Optical 
microscopy 
GUV morphology changes directly observed by optical 
microscopy (phase contrast, epifluorescence, 
fluorescence confocal) can give qualitative clues to the 
nature of material interactions with the membrane. 
52,166 
Membrane 
fluidity 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
A region of the membrane is bleached of fluorescence 
with a high energy laser of a confocal microscope. The 
rate of fluorescence recovery by dyes from outside of 
the region of interest can be quantified into a lateral 
diffusion constant of lipids. This methods assumes 
homogeneous diffusion across a larger area of 
membrane (i.e. the photobleached region) 
164,170,171 
Fluorescence 
correlation 
spectroscopy 
(FCS) 
The autocorrelation function of fluorescence fluctuations 
of a pixel on the GUV membrane is used to quantify the 
diffusion constant of fluorophore-labelled lipids or 
membrane-bound proteins. This is a more localised 
measurement than FRAP (above) and can be confined 
to the nanoscale using stimulated emission depletion 
microscopy FCS (STED-FCS172,173). 
172-180 
Mechanical 
moduli 
Micropipette 
aspiration 
GUVs are aspirated into a micropipette; stress-strain 
plots is used to quantify !!, !! and the lysis stress and 
strain. !! is difficult to measure as this requires a lot of 
data points in the low tension regime. Membrane 
contour analysis (below) can be better for measuring !!. 
123-125,181,182 
Membrane 
contour analysis 
The radial localisation of the GUV’s membrane is 
determined with sub-pixel resolution. Fitting the power 
spectrum of membrane fluctuations allows the bending 
modulus to be quantified. 
183-188 
Membrane 
permeability 
Dye translocation 
kinetics 
The rate of influx of water soluble fluorescent probes 
into GUVs can be used to quantify the membrane’s 
permeability and the fractional permeable area of 
membrane. 
189-191 
Patch-clamp 
electrophysiology 
Electrophysiological patch-clamp recordings have been 
achieved in GUVs to quantify ion permeability of 
membranes.  
192 
Membrane 
phase 
behaviour 
Fluorescent lipid 
partitioning 
Imaging the partitioning of dyes between coexisting lipid 
phases in phase separated membranes allow the study 
of membrane phase behaviour and the construction of 
phase diagrams of lipid mixtures. 
193 
Lipid packing 
and hydration 
Laurdan 
fluorescence 
The generalised polarisation function of Laurdan 
obtained from ratiometric imaging of two environment-
sensitive emission maxima reveals information about 
changes in the local structure and hydration of the 
membrane.  
165,194,195 
Membrane 
binding 
Fluorescence 
localisation 
imaging 
Imaging of fluorescent membrane-active compounds 
(e.g. proteins) can be used to semi-quantitatively 
investigate their binding at GUV membranes, including 
relative binding to different coexisting membrane 
phases or curvatures. 
49,52,99 
Flow cytometry The colocalisation of fluorescent proteins or particles 
with GUVs in flow cytometry experiments can be used 
to quantify the kinetics and extent of adsorption. 
196 
!
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Figure 4 
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Figure 7 
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